High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy

PURPOSE: To investigate the prognostic value of survivin expression in pretreatment specimens from patients with anal cancer treated with concurrent 5-FU and mitomycin C-based chemoradiation (CRT). MATERIAL AND METHODS: Immunohistochemical staining for survivin was performed in pretreatment biopsies...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraunholz, Ingeborg, Rödel, Claus, Distel, Luitpold, Rave-Fränk, Marget, Kohler, Daniela, Falk, Stefan, Rödel, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430559/
https://www.ncbi.nlm.nih.gov/pubmed/22697293
http://dx.doi.org/10.1186/1748-717X-7-88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430559/
https://www.ncbi.nlm.nih.gov/pubmed/22697293
http://dx.doi.org/10.1186/1748-717X-7-88

Ejemplares similares